Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31–46. https://doi.org/10.1158/2159-8290.CD-21-1059
Article CAS PubMed Google Scholar
Brabletz, T., Kalluri, R., Nieto, M. A., & Weinberg, R. A. (2018). EMT in cancer. Nat Rev Cancer, 18(2), 128–34. https://doi.org/10.1038/nrc.2017.118
Article CAS PubMed Google Scholar
Wechman, S. L., Emdad, L., Sarkar, D., Das, S. K., & Fisher, P. B. (2020). Vascular mimicry: Triggers, molecular interactions and in vivo models. Adv Cancer Res, 148, 27–67. https://doi.org/10.1016/bs.acr.2020.06.001
Article CAS PubMed PubMed Central Google Scholar
Zang, Y., Chaudhari, K., & Bashaw, G. J. (2021). New insights into the molecular mechanisms of axon guidance receptor regulation and signaling. Curr Top Dev Biol, 142, 147–96. https://doi.org/10.1016/bs.ctdb.2020.11
Article PubMed PubMed Central Google Scholar
Mehlen, P., Delloye-Bourgeois, C., & Chedotal, A. (2011). Novel roles for Slits and netrins: Axon guidance cues as anticancer targets? Nat Rev Cancer, 11(3), 188–97. https://doi.org/10.1038/nrc3005
Article CAS PubMed Google Scholar
Zhou, W. J., Geng, Z. H., Chi, S., Zhang, W., Niu, X. F., Lan, S. J., Ma, L., Yang, X., Wang, L. J., Ding, Y. Q., & Geng, J. G. (2011). Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res, 21(4), 609–26.
Article CAS PubMed PubMed Central Google Scholar
Tavora, B., Mederer, T., Wessel, K. J., Ruffing, S., Sadjadi, M., Missmahl, M., Ostendorf, B. N., Liu, X., Kim, J. Y., Olsen, O., Welm, A. L., Goodarzi, H., & Tavazoie, S. F. (2020). Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. Nature, 586(7828), 299–304. https://doi.org/10.1038/s41586-020-2774-y
Article CAS PubMed PubMed Central Google Scholar
Lu, G., Du, R., Dong, J., Sun, Y., Zhou, F., Feng, F., Feng, B., Han, Y., & Shang, Y. (2023). Cancer associated fibroblast derived SLIT2 drives gastric cancer cell metastasis by activating NEK9. Cell Death Dis, 14(7), 421. https://doi.org/10.1038/s41419-023-05965-z
Article CAS PubMed PubMed Central Google Scholar
Lengrand, J., Pastushenko, I., Vanuytven, S., Song, Y., Venet, D., Sarate, R. M., Bellina, M., Moers, V., Boinet, A., Sifrim, A., Rama, N., Ducarouge, B., Van Herck, J., Dubois, C., Scozzaro, S., Lemaire, S., Gieskes, S., Bonni, S., Collin, A., … Blanpain, C. (2023). Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature, 620(7973), 402–8. https://doi.org/10.1038/s41586-023-06372-2
Article CAS PubMed PubMed Central Google Scholar
Cassier, P. A., Navaridas, R., Bellina, M., Rama, N., Ducarouge, B., Hernandez-Vargas, H., Delord, J. P., Lengrand, J., Paradisi, A., Fattet, L., Garin, G., Gheit, H., Dalban, C., Pastushenko, I., Neves, D., Jelin, R., Gadot, N., Braissand, N., Leon, S., … Mehlen, P. (2023). Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature, 620(7973), 409–16. https://doi.org/10.1038/s41586-023-06367-z
Article CAS PubMed PubMed Central Google Scholar
Sung, P. J., Rama, N., Imbach, J., Fiore, S., Ducarouge, B., Neves, D., Chen, H. W., Bernard, D., Yang, P. C., Bernet, A., Depil, S., & Mehlen, P. (2019). Cancer-associated fibroblasts produce netrin-1 to control cancer cell plasticity. Cancer Res, 79(14), 3651–61. https://doi.org/10.1158/0008-5472.CAN-18-2952
Article CAS PubMed Google Scholar
Xia, X., Mao, Z., Wang, W., Ma, J., Tian, J., Wang, S., & Yin, K. (2023). Netrin-1 promotes the immunosuppressive activity of MDSCs in colorectal cancer. Cancer Immunology Research, 11(5), 600–613. https://doi.org/10.1158/2326-6066.CIR-22-0658
Article CAS PubMed Google Scholar
Worzfeld, T., & Offermanns, S. (2014). Semaphorins and plexins as therapeutic targets. Nature Reviews. Drug Discovery, 13(8), 603–621. https://doi.org/10.1038/nrd4337
Article CAS PubMed Google Scholar
Tseng, C. H., Murray, K. D., Jou, M. F., Hsu, S. M., Cheng, H. J., & Huang, P. H. (2011). Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer. PLoS One, 6(4), e19396. https://doi.org/10.1371/journal.pone.0019396
Article CAS PubMed PubMed Central Google Scholar
Chakraborty, G., Kumar, S., Mishra, R., Patil, T. V., & Kundu, G. C. (2012). Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One, 7(3), e33633. https://doi.org/10.1371/journal.pone.0033633
Article CAS PubMed PubMed Central Google Scholar
Barnkob, M. B., Michaels, Y. S., Andre, V., Macklin, P. S., Gileadi, U., Valvo, S., Rei, M., Kulicke, C., Chen, J. L., Jain, V., Woodcock, V. K., Colin-York, H., Hadjinicolaou, A. V., Kong, Y., Mayya, V., Mazet, J. M., Mead, G. J., Bull, J. A., Rijal, P., … Cerundolo, V. (2024). Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8(+) T cells. Nat Commun., 15(1), 3448. https://doi.org/10.1038/s41467-024-47775-7
Article CAS PubMed PubMed Central Google Scholar
Tominaga, K., Minato, H., Murayama, T., Sasahara, A., Nishimura, T., Kiyokawa, E., Kanauchi, H., Shimizu, S., Sato, A., Nishioka, K., Tsuji, E. I., Yano, M., Ogawa, T., Ishii, H., Mori, M., Akashi, K., Okamoto, K., Tanabe, M., Tada, K. I., … Gotoh, N. (2019). Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells. Proc Natl Acad Sci U S A, 116(2), 625–30. https://doi.org/10.1073/pnas.1806851116
Article CAS PubMed Google Scholar
Fattet, L., Jung, H. Y., Matsumoto, M. W., Aubol, B. E., Kumar, A., Adams, J. A., Chen, A. C., Sah, R. L., Engler, A. J., Pasquale, E. B., & Yang, J. (2020). Matrix rigidity controls epithelial-mesenchymal plasticity and tumor metastasis via a mechanoresponsive EPHA2/LYN complex. Dev Cell, 54(3), 302–16.e7. https://doi.org/10.1016/j.devcel.2020.05.031
Article CAS PubMed PubMed Central Google Scholar
Lee, P. C., Chen, S. T., Kuo, T. C., Lin, T. C., Lin, M. C., Huang, J., Hung, J. S., Hsu, C. L., Juan, H. F., Lee, P. H., & Huang, M. C. (2020). C1GALT1 is associated with poor survival and promotes soluble ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Oncogene, 39(13), 2724–40. https://doi.org/10.1038/s41388-020-1178-7
Article CAS PubMed PubMed Central Google Scholar
Takasugi, M., Okada, R., Takahashi, A., Virya Chen, D., Watanabe, S., & Hara, E. (2017). Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat Commun, 8, 15729. https://doi.org/10.1038/ncomms15728
Article CAS PubMed PubMed Central Google Scholar
Gao, Z., Han, X., Zhu, Y., Zhang, H., Tian, R., Wang, Z., Cui, Y., Wang, Z., Niu, R., & Zhang, F. (2021). Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling. Cell Death Dis, 12(5), 414. https://doi.org/10.1038/s41419-021-03692-x
Article CAS PubMed PubMed Central Google Scholar
Oudin, M. J., Jonas, O., Kosciuk, T., Broye, L. C., Guido, B. C., Wyckoff, J., Riquelme, D., Lamar, J. M., Asokan, S. B., Whittaker, C., Ma, D., Langer, R., Cima, M. J., Wisinski, K. B., Hynes, R. O., Lauffenburger, D. A., Keely, P. J., Bear, J. E., & Gertler, F. B. (2016). Tumor cell-driven extracellular matrix remodeling drives haptotaxis during metastatic progression. Cancer Discov, 6(5), 516–31. https://doi.org/10.1158/2159-8290.CD-15-1183
Article CAS PubMed PubMed Central Google Scholar
Hughes, S. K., Oudin, M. J., Tadros, J., Neil, J., Del Rosario, A., Joughin, B. A., Ritsma, L., Wyckoff, J., Vasile, E., Eddy, R., Philippar, U., Lussiez, A., Condeelis, J. S., van Rheenen, J., White, F., Lauffenburger, D. A., & Gertler, F. B. (2015). PTP1B-dependent regulation of receptor tyrosine kinase signaling by the actin-binding protein Mena. Mol Biol Cell, 26(21), 3867–78. https://doi.org/10.1091/mbc.E15-06-0442
Article CAS PubMed PubMed Central Google Scholar
Oudin, M. J., Barbier, L., Schafer, C., Kosciuk, T., Miller, M. A., Han, S., Jonas, O., Lauffenburger, D. A., & Gertler, F. B. (2017). MENA confers resistance
Comments (0)